MeVis Medical Solutions AG (M3V.DE) has a profit margin of 8.94%, below the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for M3V.DE is 8.94% as of March 2026. That compares with 25.87% in the prior-year period — down 65.4% year over year. That is below the sector sector average of 13.4%. Investors often review this figure alongside MeVis Medical Solutions AG's historical trend and sector peers before judging valuation or financial health.
Over the past year, M3V.DE's profit margin moved from 25.87% to 8.94% — a 65.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MeVis Medical Solutions AG's valuation or profitability profile.
Against its sector companies, M3V.DE currently prints 8.94% for profit margin, while the sector average sits near 13.4%. That is roughly 33.3% below the sector mean. Large gaps often invite a closer look at MeVis Medical Solutions AG's growth, margins, and balance sheet.
Profit Margin shows how effectively MeVis Medical Solutions AG converts resources into returns. At 8.94%, M3V.DE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 25.87% in the prior-year period — down 65.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting M3V.DE's profit margin (8.94%), review year-over-year change from 25.87%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.